Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 17.28% vs -54.72% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is -2.24% vs 0.19% in Mar 2024
Investments
YoY Growth in year ended Mar 2025 is 17.81% vs 56.99% in Mar 2024
Current Assets
YoY Growth in year ended Mar 2025 is 0.77% vs 3.55% in Mar 2024
Compare Balance Sheet Results of Samrat Pharma
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
3.09
33.00
-29.91
-90.64%
Share Warrants & Outstandings
Total Reserve
68.71
6.46
62.25
963.62%
Shareholder's Funds
71.80
39.46
32.34
81.96%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
0.00
0.38
-0.38
-100.00%
Secured Loans
0.00
0.15
-0.15
-100.00%
Unsecured Loans
0.00
0.23
-0.23
-100.00%
Deferred Tax Assets / Liabilities
0.11
0.33
-0.22
-66.67%
Other Long Term Liabilities
0.00
0.00
0.00
0.00%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
0.00
0.13
-0.13
-100.00%
Total Non-Current Liabilities
0.11
0.84
-0.73
-86.90%
Current Liabilities
Trade Payables
38.70
17.76
20.94
117.91%
Other Current Liabilities
0.94
3.57
-2.63
-73.67%
Short Term Borrowings
9.91
10.21
-0.30
-2.94%
Short Term Provisions
0.02
0.08
-0.06
-75.00%
Total Current Liabilities
49.58
31.62
17.96
56.80%
Total Liabilities
121.49
71.91
49.58
68.95%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
16.85
10.98
5.87
53.46%
Less: Accumulated Depreciation
6.37
1.37
5.00
364.96%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
10.48
9.61
0.87
9.05%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
0.00
0.00
0.00
0.00%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
3.44
0.00
3.44
0.00%
Long Term Loans & Advances
0.75
0.17
0.58
341.18%
Other Non Current Assets
3.46
0.00
3.46
0.00%
Total Non-Current Assets
18.13
12.41
5.72
46.09%
Current Assets Loans & Advances
Current Investments
0.36
0.00
0.36
0.00%
Inventories
38.01
23.24
14.77
63.55%
Sundry Debtors
56.54
34.95
21.59
61.77%
Cash and Bank
0.16
0.06
0.10
166.67%
Other Current Assets
0.17
0.00
0.17
0.00%
Short Term Loans and Advances
8.13
1.25
6.88
550.40%
Total Current Assets
103.36
59.50
43.86
73.71%
Net Current Assets (Including Current Investments)
53.78
27.88
25.90
92.90%
Total Current Assets Excluding Current Investments
103.00
59.50
43.50
73.11%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
121.49
71.91
49.58
68.95%
Contingent Liabilities
0.00
0.00
0.00
0.00%
Total Debt
9.91
10.59
-0.68
-6.42%
Book Value per share (adjusted)
232.39
11.42
220.97
1,934.94%
Annual - Borrowings
Borrowings 9.91 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 17.28% vs -54.72% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 10.48 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -2.24% vs 0.19% in Mar 2024
Annual - Investments
Investments 3.44 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 17.81% vs 56.99% in Mar 2024
Annual - Current Assets
Current Assets 103.36 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 0.77% vs 3.55% in Mar 2024
